Gauri Saini
?v?6 integrin may be a potential prognostic biomarker in interstitial lung disease
Saini, Gauri; Porte, Joanne; Weinreb, Paul H; Violette, Sheila M; Wallace, William A; McKeever, Tricia M.; Jenkins, Gisli
Authors
Joanne Porte
Paul H Weinreb
Sheila M Violette
William A Wallace
TRICIA MCKEEVER tricia.mckeever@nottingham.ac.uk
Professor of Epidemiology and Medical Statistics
Gisli Jenkins
Abstract
Idiopathic pulmonary fibrosis (IPF) and fibrotic nonspecific interstitial pneumonitis are progressive interstitial lung diseases (ILDs) with limited treatment options and poor survival. However, the rate of disease progression is variable, implying there may be different endotypes of disease. We hypothesised that immunophenotyping biopsies from ILD patients might reveal distinct endotypes of progressive fibrotic disease, which may facilitate stratification when undertaking clinical trials of novel therapies for IPF.43 paraffin-embedded, formalin-fixed lung tissue sections were immunostained for five molecules implicated in the pathogenesis of the fibrosis: ?-smooth muscle actin (?SMA), ?v?6 integrin, pro-surfactant protein C (SP-C), hepatocyte growth factor (HGF) and tenascin-C (TenC). Levels of immunostaining and numbers of fibroblastic foci were quantified using operator-dependent and -independent methods. The relationship of all these markers to overall survival was analysed.Staining revealed high levels of ?SMA, ?v?6 integrin, pro-SP-C, HGF and TenC, and fibroblastic foci. Immunostaining varied across samples for all molecules but only the extent of ?v?6 integrin immunostaining was associated with increased mortality. There was no association with the other markers measured.Our data suggest high levels of ?v?6 integrin may identify a specific endotype of progressive fibrotic lung disease.
Citation
Saini, G., Porte, J., Weinreb, P. H., Violette, S. M., Wallace, W. A., McKeever, T. M., & Jenkins, G. (2015). ?v?6 integrin may be a potential prognostic biomarker in interstitial lung disease. European Respiratory Journal, 46(2), 486-494. https://doi.org/10.1183/09031936.00210414
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 16, 2015 |
Online Publication Date | Mar 5, 2015 |
Publication Date | 2015-08 |
Deposit Date | May 8, 2017 |
Publicly Available Date | May 8, 2017 |
Journal | European Respiratory Journal |
Print ISSN | 0903-1936 |
Electronic ISSN | 1399-3003 |
Publisher | European Respiratory Society |
Peer Reviewed | Peer Reviewed |
Volume | 46 |
Issue | 2 |
Pages | 486-494 |
DOI | https://doi.org/10.1183/09031936.00210414 |
Public URL | https://nottingham-repository.worktribe.com/output/748075 |
Publisher URL | http://erj.ersjournals.com/content/46/2/486 |
Files
Saini et al ERJ Clean copy Dec 2014 (002).pdf
(<nobr>233 Kb</nobr>)
PDF
Figure 4.jpg
(<nobr>104 Kb</nobr>)
Image
You might also like
Loss of ELK1 has differential effects on age-dependent organ fibrosis
(2019)
Journal Article
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
(2019)
Journal Article